Comparison · NCT05486416-4ee98e9d
HSK3486 for General Anesthesia Induction vs Propofol for General Anesthesia Induction: Percentage of Subjects With Successful Induction Who Maintain the Desired Depth of Anesthesia for General Elective Surgery, AND Without Significant Cardiac and Respiratory Depression
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. HSK3486 for General Anesthesia Induction vs Propofol for General Anesthesia Induction: Percentage of Subjects With Successful Induction Who Maintain the Desired Depth of Anesthesia for General Elective Surgery, AND Without Significant Cardiac and Respiratory Depression. Trial comparisons, record NCT05486416-4ee98e9d. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT05486416-4ee98e9d
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.27 | 0.223 | 0.323 | wilson | |
| Risk in group 2 | 0.31 | 0.241 | 0.39 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0403 | -0.133 | 0.0471 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.87 | 0.641 | 1.18 | log | |
| Odds ratio, group 1 over group 2 | 0.822 | 0.532 | 1.27 | log | |
| Number needed to treat, for one fewer participant with the outcome on HSK3486 for General Anesthesia Induction than on Propofol for General Anesthesia Induction | 24.8 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | HSK3486 for General Anesthesia Induction | HSK3486 for induction of general anesthesia~HSK3486: HSK3486 for induction of general anesthesia | 81 | 300 | OG000 |
| Group 2 | Propofol for General Anesthesia Induction | Propofol for induction of general anesthesia~Propofol: Propofol for induction of general anesthesia | 45 | 145 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Percentage of Subjects With Successful Induction Who Maintain the Desired Depth of Anesthesia for General Elective Surgery, AND Without Significant Cardiac and Respiratory Depression
- Description
The outcome is defined by all the following conditions:~a) Desired depth of anesthesia for general elective surgery is defined if all following criteria are met: i) No clinical signs of inadequate depth of anesthesia, such as lacrimation, movement, vomiting, coughing, laryngospasm, bucking, swallowing reflex or bronchospasm etc.~ii) No blood pressure (SBP, DBP, or MAP) increases more than 20% from baseline in response to any major operational procedures or noxious stimulus in defined period.~iii) Subjects maintain desired depth of anesthesia for general elective surgery with BIS as an objective assessment (after reaching initial lowest value, BIS remains sustainable level at not more than 60).~b) No significant respiratory depression, such as apnea, prior to the administration of rocuronium bromide.~c) No significant cardiac depression indicated by blood pressure decrease that requires intervention, i.e., vasopressors and/or IV fluid resuscitation.
- Time frame
- 15 minutes from end of drug administration
- Population
Source ClinicalTrials.gov
Trial
- Title
- Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery
- NCT number
- NCT05486416
- Phases
- PHASE3
- Conditions
- General Anesthesia
- Interventions
- HSK3486, Propofol
- Lead sponsor
- Haisco-USA Pharmaceuticals, Inc.
- Results first posted
- 2025-08-11
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT05486416?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT05486416-4ee98e9d